GGrantIndex
Sort

85,873 grants matching alzheimers

The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome

$3,260,720
Jorge A Busciglio · University Of California-Irvine · RF1 · FY2018 · AG

Pin1 Regulation in Evolving Alzheimer’s Disease

$3,257,680
James S. Malter · Ut Southwestern Medical Center · RF1 · FY2019 · AG

The regulation of synaptic transmission and neural circuit function

$3,255,450
Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Inhibition of BACE1 for benefiting Alzheimer's patients

$3,255,415
Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2018 · AG

Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil

$3,251,970
David A Bennett · Rush University Medical Center · R01 · FY2025 · AG

IMPACT AND MECHANISMS OF VASCULAR OXIDATIVE STRESS ON CAA PATHOGENESIS AND CAA-RELATED DEMENTIA

$3,251,568
Gregory J Zipfel · Washington University · RF1 · FY2018 · NS

Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias

$3,251,295
Amber E Barnato · Dartmouth College · P01 · FY2024 · AG

Alzheimer's Disease Research Center

$3,249,827
Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2021 · AG

UCSD Alzheimer's Disease Research Centers P30

$3,248,425
James B Brewer · University Of California, San Diego · P30 · FY2021 · AG

Core E: Omics Core

$3,248,017
Sid E O'Bryant · University Of Pittsburgh At Pittsburgh · U19 · FY2021 · AG

The Four Repeat Tauopathy Neuroimaging Initiative

$3,247,823
Adam L Boxer · University Of California, San Francisco · R01 · FY2016 · AG

Alzheimer's Disease Genetics Consortium

$3,247,012
Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2014 · AG

Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease

$3,246,490
Berislav V Zlokovic · University Of Southern California · P01 · FY2022 · AG

Conformational polymorphisms of amyloid in AD and immunological biomarkers and therapeutics

$3,245,609
Charles G Glabe · University Of California-Irvine · RF1 · FY2018 · AG

Core E: Omics Core

$3,244,356
Sid E O'Bryant · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG

Cognition & Hippocampal/Cortical Systems in Aging

$3,243,918
Michela Gallagher · Johns Hopkins University · P01 · FY2022 · AG

High resolution longitudinal immune monitoring for elucidating immune aging dynamics

$3,242,451
Mark M Davis · Stanford University · P01 · FY2025 · AI

Influence of Interpersonal Connectedness in Spousal Care Dyads on Early Progression of AD

$3,240,750
Kuan-Hua Chen · University Of Nebraska Medical Center · RF1 · FY2025 · AG

Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease

$3,239,892
John M. Sedivy · Brown University · P01 · FY2023 · AG

The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)

$3,236,413
Charles Decarli · University Of California At Davis · U19 · FY2020 · NS

Metformin in Alzheimer's dementia Prevention (MAP)

$3,234,307
Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2020 · AG

Diabetes and brain amyloid in middle aged Hispanics

$3,234,050
Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2021 · AG

A Systems Approach to Targeting Innate Immunity in AD

$3,233,653
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U01 · FY2020 · AG

Cognition & Hippocampal/Cortical Systems in Aging

$3,232,997
Michela Gallagher · Johns Hopkins University · P01 · FY2021 · AG

ALZHEIMER'S DISEASE PATHWAYS AND BIOMARKER DISCOVERY BY INTEGRATIVE PROTEOMICS, GLYCOPROTEOMICS, AND GLYCOMICS

$3,232,393
Lian Li · Emory University · RF1 · FY2018 · AG